publication venue for
- Body Mass Index Does Not Impact Clinical Efficacy of Ustekinumab in Crohn’s Disease: A Post Hoc Analysis of the IM-UNITI Trial. 27:848-854. 2021
- Salicylates Ameliorate Intestinal Inflammation by Activating Macrophage AMPK. 27:914-926. 2021
- Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey. 27:836-847. 2021
- Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane Reviews 2021
- Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. 26:1796-1807. 2020
- Age-Related Survival Differences in Patients With Inflammatory Bowel Disease–Associated Colorectal Cancer: A Population-Based Cohort Study. 25:1957-1965. 2019
- Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn’s Disease. 25:1796-1804. 2019
- Response to Letter by Moulton et al.. 25:e99-e99. 2019
- Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease. 25:1255-1261. 2019
- Antibiotics Potentiate Adherent-InvasiveE. coliInfection and Expansion. 25:711-721. 2019
- Appropriateness of Biologics in the Management of Crohn’s Disease Using RAND/UCLA Appropriateness Methodology. 25:328-335. 2019
- Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn’s Disease: The Toronto Consensus. 25:1-13. 2019
- The Role of Biomarkers in Clinical Trials of Inflammatory Bowel Disease. 24:1619-1623. 2018
- Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD. 23:1950-1961. 2017
- Systematic Review and Meta-analysis. 23:1702-1709. 2017
- Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.. 23:1702-1709. 2017
- Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease. 23:858-865. 2017
- Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011. 23:868-874. 2017
- Development of the IBD Disk. 23:333-340. 2017
- Adverse Events During Anti-TNFα Therapies in IBD (Excluding Infections and Malignancies). 22:1239-1245. 2016
- New Applications for Traditional Drugs in Inflammatory Bowel Disease. 21:2948-2957. 2015
- Ecobiotherapy Rich in Firmicutes Decreases Susceptibility to Colitis in a Humanized Gnotobiotic Mouse Model. 21:1883-1893. 2015
- Systematic Review. 21:1683-1694. 2015
- Anti-TNFα Therapies Are Safe During Pregnancy in Women with Inflammatory Bowel Disease. 20:1862-1869. 2014
- The Commensal Bacterium Faecalibacterium prausnitzii Is Protective in DNBS-induced Chronic Moderate and Severe Colitis Models. 20:417-430. 2014
- Hepatotoxicity Caused by Methotrexate Therapy in Children with Inflammatory Bowel Disease. 20:47-59. 2014
- P-181 YI Inflammatory Bowel Disease Nurses in Canada. 19:S98-S99. 2013
- Reduced Fat Oxidation Rates During Submaximal Exercise in Adolescents with Crohnʼs Disease. 19:2659-2665. 2013
- The Utility of Screening for Asymptomatic Lower Extremity Deep Venous Thrombosis during Inflammatory Bowel Disease Flares. 19:1053-1058. 2013
- Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes. 19:332-341. 2013
- IL-10R Polymorphisms Are Associated with Very-early-onset Ulcerative Colitis. 19:115-123. 2013
- Commensal and Probiotic Bacteria Influence Intestinal Barrier Function and Susceptibility to Colitis in Nod1−/−;Nod2−/− Mice. 18:1434-1446. 2012
- Differences of small intestinal bacteria populations in adults and children with/without celiac disease: Effect of age, gluten diet, and disease. 18:649-656. 2012
- Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease. 17:1451-1463. 2011
- Practice of gastroenterologists in treating flaring inflammatory bowel disease patients with clostridium difficile. 17:1540-1546. 2011
- Pediatric modification of the Montreal classification for inflammatory bowel disease. 17:1314-1321. 2011
- Assessment of knowledge in adolescents with inflammatory bowel disease using a novel transition tool. 17:1131-1137. 2011
- Assessing disease activity in ulcerative colitis. 16:651-656. 2010
- Effects of mesalamine (5-aminosalicylic acid) on bacterial gene expression. 15:985-996. 2009
- Are there epidemiological differences between crohnʼs disease and ulcerative colitis?. 14:S1-S1. 2008
- CARD15 and IL23R influences Crohnʼs disease susceptibility but not disease phenotype in a Brazilian population. 14:674-679. 2008
- Intestinal epithelial barrier dysfunction and dendritic cell redistribution during early stages of inflammation in the rat: Role for TLR-2 and -4 blockage. 14:632-644. 2008
- Characterization of ileal dendritic cell distribution in a rat model of acute and chronic inflammation. 12:457-470. 2006
- Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: Prevalence and impact on health. 12:38-46. 2006
- Positron Emission Tomography in the Investigation of Pediatric Inflammatory Bowel Disease. 11:733-738. 2005
- All Patients with Inflammatory Bowel Disease Should Have Bone Density Assessment: Pro. 7:158-162. 2001
- Well-Adjusted Children: An Alternate View of Children with Inflammatory Bowel Disease and Functional Gastrointestinal Complaints. 6:1-7. 2000
- Bone Mineral Metabolism In Pediatric Inflammatory Bowel Disease. 5:192-199. 1999
- “Immune/Non-Immune Cell Interactions in Intestinal Inflammation” Workshop. 3:133-141. 1997
- “Immune/non-immune cell interactions in intestinal inflammation” workshop. 3:133-141. 1997
- HISTOLOGICAL AND ENDOSCOPIC HEALING AFTER QBECO TREATMENT IN AN OPEN-LABEL PHASE 2 STUDY IN PATIENTS WITH ULCERATIVE COLITIS 2018
- Allied Health Professional Support in Pediatric Inflammatory Bowel Disease: A Survey from the Canadian Pediatric IBD Network 2017
- Early Use of Therapeutic Drug Monitoring to Individualize Infliximab Therapy in Paediatric IBD, a Multicentre Prospective Study 2017
- Proximal Disease Extension in Limited Ulcerative Colitis: A Systematic Review and Meta-Analysis 2017
- Mucosal Healing Is Associated with Improved Long-Term Outcomes in Crohn's Disease: A Systematic Review and Meta-analysis 2016
- Mucosal Healing Is Associated with Improved Long-Term Outcomes in Ulcerative Colitis: A Systematic Review and Meta-analysis 2016
- P-064 Impact of High Dose Vitamin D3 Supplementation in Treatment of Crohnʼs Disease in Remission 2016
- P-079 YI The Association Between Anxiety and Depression and Health Related Quality of Life in Patients with Inflammatory Bowel Disease (IBD) 2016
- P-231 YI Patient Experience Living with Inflammatory Bowel Disease 2016
- Does Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease Impact Clinical Management? A Canadian Experience. 2012
- Validation and Comparison of Algorithms to Identify Adult-Onset Inflammatory Bowel Disease Patients From Within Health Administrative Data 2012
- Development of a specialist nurse educational program: The NIICE (Nurses Initiative in IBD Care and Education) in Canada Program 2011
- Evolution of the phenotypic characteristics of pediatric Inflammatory Bowel Disease using the Paris classification 2011
- Interdisciplinary, prompt access IBD clinic: The hamilton health science experience 2011
- Exploring the reliability of phenotypic assignment for pediatric inflammatory bowel disease. 2011
- Severe neutropenia following a single infliximab infusion in a child with Crohn disease 2009
- Infliximab-induced psoriasis in pediatric Crohn Disease; Experience of this paradoxical event at a tertiary centre 2008
- Life threatening complications of sulphasalazine therapy in pediatric inflammatory bowel disease 2008
- Discontinuation of immunomodulator therapy in infliximab-treated children with Crohn disease; one year outcome evaluating influences on disease activity and infliximab antibody formation 2008
- The Vagus Nerve 2006